ARTICLE | Company News
Cincinnati Children's Hospital, Calimmune deal
December 9, 2016 8:26 PM UTC
Calimmune gained rights to develop and commercialize ex vivo autologous gene therapies using the hospital's lentiviral hemoglobin subunit gamma (HBG) globin gene construct to treat sickle cell disease...